• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

WHO subvariants of indolent mastocytosis: clinical details and prognostic evaluation in 159 consecutive adults.

作者信息

Pardanani Animesh, Lim Ken-Hong, Lasho Terra L, Finke Christy M, McClure Rebecca F, Li Chin-Yang, Tefferi Ayalew

出版信息

Blood. 2010 Jan 7;115(1):150-1. doi: 10.1182/blood-2009-10-249979.

DOI:10.1182/blood-2009-10-249979
PMID:20056798
Abstract
摘要

相似文献

1
WHO subvariants of indolent mastocytosis: clinical details and prognostic evaluation in 159 consecutive adults.
Blood. 2010 Jan 7;115(1):150-1. doi: 10.1182/blood-2009-10-249979.
2
Systemic mastocytosis.系统性肥大细胞增生症。
Am J Med Sci. 2011 Nov;342(5):409-15. doi: 10.1097/MAJ.0b013e3182121131.
3
Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors.342例连续成年系统性肥大细胞增多症患者的生存研究及预后因素
Blood. 2009 Jun 4;113(23):5727-36. doi: 10.1182/blood-2009-02-205237. Epub 2009 Apr 10.
4
Comparison between indolent systemic mastocytosis and clonal mast cell disease not meeting WHO diagnostic criteria: A nationwide multicenter retrospective analysis.惰性系统性肥大细胞增多症与不符合世界卫生组织诊断标准的克隆性肥大细胞疾病的比较：一项全国多中心回顾性分析。
Hematol Oncol. 2024 May;42(3):e3277. doi: 10.1002/hon.3277.
5
How we diagnose and treat WHO-defined systemic mastocytosis in adults.我们如何诊断和治疗世界卫生组织定义的成人系统性肥大细胞增多症。
Haematologica. 2008 Jan;93(1):6-9. doi: 10.3324/haematol.12324.
6
Systemic mastocytosis: retrospective review of a decade's clinical experience at the Brigham and Women's Hospital.系统性肥大细胞增多症：布莱根妇女医院十年临床经验回顾
J Invest Dermatol. 1991 Mar;96(3 Suppl):5S-13S; discussion 13S-14S, 60S-65S. doi: 10.1111/1523-1747.ep12468899.
7
Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients.成人惰性系统性肥大细胞增多症的预后：西班牙肥大细胞增多症网络对145例患者的长期研究
J Allergy Clin Immunol. 2009 Sep;124(3):514-21. doi: 10.1016/j.jaci.2009.05.003. Epub 2009 Jul 9.
8
Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients.全身性肥大细胞增多症的临床表现和治疗方法。意大利 460 例患者的调查。
Am J Hematol. 2016 Jul;91(7):692-9. doi: 10.1002/ajh.24382. Epub 2016 Jun 2.
9
Indolent systemic mastocytosis: a case and review of the current available treatment options.
Dermatol Online J. 2013 Jun 15;19(6):18562.
10
Two cases of concomitant acquired aplastic anemia and systemic mastocytosis.两例获得性再生障碍性贫血伴系统性肥大细胞增多症。
Hum Pathol. 2014 Feb;45(2):417-20. doi: 10.1016/j.humpath.2013.08.002. Epub 2013 Oct 31.

引用本文的文献

1
Clinical and Biological Characteristics of Four Patients with Aggressive Systemic Mastocytosis Treated with Midostaurin.米哚妥林治疗的4例侵袭性系统性肥大细胞增多症患者的临床和生物学特征
Biomedicines. 2025 Jul 7;13(7):1655. doi: 10.3390/biomedicines13071655.
2
Mastocytosis in the Skin: Approach to Diagnosis, Evaluation, and Management in Adult and Pediatric Patients.皮肤肥大细胞增多症：成人及儿童患者的诊断、评估与管理方法
Am J Clin Dermatol. 2025 May 20. doi: 10.1007/s40257-025-00947-7.
3
Characterization of patients with clonal mast cells in the bone marrow with clinical significance not otherwise specified.
骨髓中具有克隆性肥大细胞且临床意义未另行明确的患者特征。
EClinicalMedicine. 2025 Jan 10;80:103043. doi: 10.1016/j.eclinm.2024.103043. eCollection 2025 Feb.
4
Genetic Changes in Mastocytes and Their Significance in Mast Cell Tumor Prognosis and Treatment.肥大细胞的基因变化及其在肥大细胞瘤预后和治疗中的意义。
Genes (Basel). 2024 Jan 22;15(1):137. doi: 10.3390/genes15010137.
5
Review and Updates on Systemic Mastocytosis and Related Entities.系统性肥大细胞增多症及相关疾病的综述与更新
Cancers (Basel). 2023 Nov 28;15(23):5626. doi: 10.3390/cancers15235626.
6
Recent advances in diagnosis and therapy in systemic mastocytosis.系统性肥大细胞增多症诊断与治疗的最新进展
Blood Res. 2023 Apr 30;58(S1):96-108. doi: 10.5045/br.2023.2023024.
7
Perceptions of patient disease burden and management approaches in systemic mastocytosis: Results of the TouchStone Healthcare Provider Survey.系统性肥大细胞增多症患者疾病负担及治疗方法的认知：TouchStone 医疗保健提供者调查结果。
Cancer. 2022 Oct;128(20):3700-3708. doi: 10.1002/cncr.34421. Epub 2022 Aug 23.
8
Histopathology and Molecular Genetics in Systemic Mastocytosis: Implications for Clinical Management.系统性肥大细胞增多症的组织病理学和分子遗传学：对临床管理的影响。
Int J Mol Sci. 2022 Aug 7;23(15):8772. doi: 10.3390/ijms23158772.
9
Systemic Mastocytosis and Other Entities Involving Mast Cells: A Practical Review and Update.系统性肥大细胞增多症及其他涉及肥大细胞的疾病：实用综述与更新
Cancers (Basel). 2022 Jul 17;14(14):3474. doi: 10.3390/cancers14143474.
10
Efficacy of avapritinib versus best available therapy in the treatment of advanced systemic mastocytosis.阿伐普利替尼对比最佳可用疗法治疗晚期系统性肥大细胞增多症的疗效。
Leukemia. 2022 Aug;36(8):2108-2120. doi: 10.1038/s41375-022-01615-z. Epub 2022 Jul 5.